Welcome Guest
Home > Clinical Leukemia > Volume 1 |  Issue 3 > Article Abstract

Abstract
Back to TOC
Add to Favorites
X
  • Volume 1
  •  Issue 3
    • Publication Date: March 2007


Effective Therapy with Thalidomide/Lovastatin in a Patient with Primary Plasma Cell Leukemia


Marek Hus, Marta Szostek, Norbert Grzasko, Dariusz Jawniak, Malgorzata Kowal, Anna Dmoszynska

A 61-year-old man with plasma cell leukemia was treated with thalidomide, lovastatin and dexamethasone. Lovastatin was added to the usual thalidomide/dexamethasone regimen after obtaining the results of short-term culture, which revealed that thalidomide/lovastatin produced a higher rate of apoptosis, compared with apoptosis induced by each drug alone. Thirty-six months after the beginning of the therapy, the patient is still in complete hematologic remission.

Key words: Apoptosis, Dexamethasone, Myeloma


  1. https://www.ceteresopolitano.org/
  2. https://www.crossingstoronto.com/
  3. https://www.jediism.org/
  4. https://www.badenumc.org/
  5. https://www.johnsevierchapter.org/
  6. https://www.trinitychapelmn.org/
  7. https://www.photogearnews.com/
  8. https://www.alz-nova.org/
  9. https://www.cigjournals.com/
  10. https://summa-edu.com/
  11. https://cpawilmingtonnc.org/
  12. https://bimometals.com/
  13. https://sosenvironmental.com/
  14. https://thefriary.org/
  15. https://post5theatre.org/
  1. KELUARAN SGP
  2. TOGEL